Results 251 to 260 of about 126,514 (307)

Evaluating the Endocrine‐Disrupting and Oxidative Stress Potential of a 50‐Component Human‐Relevant Complex Chemical Mixture Using In Vitro Tests

Journal of Applied Toxicology, Volume 46, Issue 6, Page 2003-2018, June 2026.
ABSTRACT Humans are chronically exposed to mixtures of environmental contaminants. Exposure to endocrine‐disrupting chemicals (EDCs) contributes to increased health impairment observed globally. This study aimed to evaluate the endocrine‐disruptive and oxidative stress potential of a human‐relevant, complex chemical mixture in vitro.
Josefin Engelhardt, Nathalie Struwe, Annika Jansson, Vesna Munic Kos, Maria Larsson, Jana M. Weiss   +5 more
wiley   +1 more source

Impaired redox adaptation through SLC38A5-dependent glutamine metabolism contributes to melatonin-mediated anoikis sensitivity and metastasis suppression in bone cancer. [PDF]

Int J Biol Sci
Nguyen BT, Chen WC, Fong YC, Ko CY, Chen HT, Hsu CJ, Huynh KT, Huang WC, Yang SF, Tang CH.   +9 more
europepmc   +1 more source

Single-Cell RNA Analysis of Murine Osteosarcoma Uncovers Skp2 Function in Metastasis, Genomic Instability, and Immune Activation and Reveals Additional Target Pathways. [PDF]

Cancer Res Commun
Ferrena A, Zhang R, Wang J, Wang J, Zheng XY, Göker B, Barotti G, Borjihan H, Chae SS, Lo Y, Zhao H, Schwartz EL, Offenbacher R, Loeb DM, Yang R, Sidoli S, Geller D, Zheng D, Hoang B.   +18 more
europepmc   +1 more source

RETRACTION: LncRNA SNHG4 Promotes Tumour Growth by Sponging miR-224-3p and Predicts Poor Survival and Recurrence in Human Osteosarcoma. [PDF]

Cell Prolif
europepmc   +1 more source

Integrative biomarker and drug target discovery in osteosarcoma: traditional experimental approaches and AI-enabled insights. [PDF]

Front Pharmacol
Gao Z, Wu C.
europepmc   +1 more source

lncRNA FBXL19-AS1 Regulates Osteosarcoma Cell Proliferation, Migration and Invasion by Sponging miR-346 [Retraction]. [PDF]

Onco Targets Ther
europepmc   +1 more source

Long-Term Kidney Outcomes in Paediatric Osteosarcoma Survivors: A 20-Year Multi-Centre Study. [PDF]

Cancers (Basel)
Mak CY, Ku DT, Liu AP, Lee V, Yau JP, Fu EC, Lu ER, Shing MM, Ho IY, Pak WW, Yap DY, Leung AW, Cheng FW, Ma AL, Chan EY.   +14 more
europepmc   +1 more source

Advances in Nano-Drug Delivery Systems for Osteosarcoma: From Targeting Strategies to Combating Lung Metastasis. [PDF]

Int J Nanomedicine
Jia S, Gong B, Chen H, Chen Y, Zhuo C, Wu H, Qu X, Cai H.   +7 more
europepmc   +1 more source

Can we quantify a safe margin to reduce local recurrence in parosteal osteosarcomas around the distal femur? A cohort study based on 27 patients. [PDF]

Acta Orthop
Rasappan K, Papalia GF, Evans S, Parry M, Stevenson J, Morris G, Jeys L, Kurisunkal V.   +7 more
europepmc   +1 more source